Breakthrough in Peripheral Vascular Devices Market Size:

InsightAce Analytics Sp. Ltd. announces the publication of a market assessment report on ‘Global Peripheral Vascular Devices Market’ by Product Type (Aortic Stent Grafts, Carotid and Renal Artery Closure Devices, Inferior Vena Caval Filters (IVCF), Peripheral Embolism Protection Devices, Guidewires peripheral, peripheral vascular stents, PTA balloon catheters, PTA peripheral drug release catheters, DEB catheters, renal denervation catheters, tip locators, vascular grafts), end users (hospitals, ambulatory care centers, clinics specialized and others), Trends, industry competition analysis, revenues and forecast until 2031.”

Request for sample pages: https://www.insightaceanalytic.com/request-sample/1054

According to the latest research by InsightAce Analytic, the global peripheral vascular devices market is valued at USD 10.46 billion in 2023 and is expected to reach USD 17.75 billion by 2031, at a CAGR of 6.87% during the forecast period of 2024-2031.

Narrowing of the arteries outside the brain and heart is called peripheral vascular disease (PVD). Hypertension, diabetes, obesity and smoking are risk factors for the progression of PVD. Peripheral vascular devices are used to treat blocked arteries and eliminate plaque buildup. The most commonly used devices for the treatment of PVD are peripheral angioplasty balloon catheters, peripheral vascular stents, and aortic stents. The narrowing or blockage of blood vessels caused by plaque build-up is known as peripheral arterial disease (PAD). If left untreated, this disease can result in tissue death, heart stroke, aneurysm or kidney failure. Due to minimally invasive endovascular therapy, the increasing incidence of diseases such as diabetes and obesity, and the increasing aging of the population, peripheral vascular devices will be in high demand.

The global peripheral vascular device market is expected to expand during the forecast period owing to the increasing incidence of peripheral arterial disease. The global peripheral vascular device market is expected to expand due to increasing awareness about peripheral vascular diseases. Additionally, the growing number of geriatric diseases is expected to increase the demand for peripheral vascular devices. For industry participants in the global Peripheral Vascular Devices market, R&D in peripheral catheters is expected to provide lucrative growth prospects. Additionally, the increased demand for peripheral vascular devices is expected to be driven by the increased incidence of type 2 diabetes and hypertension. Major market players are also focusing on approving and releasing new gadgets to expand their product line. The global peripheral vascular device market is expected to grow slowly due to infections caused by peripheral vascular implants. Foreign body insertion has become a key element of medical care, but medical devices carry the risk of bacterial and fungal infection. Peripheral vascular implants have a higher risk of disease than other types of implants because they come into direct contact with the body.

North America is expected to account for the largest share of the peripheral vascular devices market during the forecast years. The market is expected to grow as more people become aware of the many treatment options available, as technological advances become more widely embraced, and as public and commercial sector investment increases in the peripheral vascular device market. The regulatory environment for the global North American peripheral vascular device market has also improved due to advances in minimally invasive surgery and increased awareness of peripheral vascular diseases. Additionally, the peripheral vascular devices market in Asia Pacific is expected to grow significantly during the forecast period due to changing dietary trends, aging population, and increased awareness of customized and modified diets. Due to the huge number of people with unmet medical needs Furthermore, the rapid development of healthcare infrastructure and rising levels of disposable income for patients in emerging economies such as India and China are likely to create future growth opportunities for the global industry.

Order this premium report: https://www.insightaceanalytic.com/buy-report/1054

The major market players operating in the peripheral vascular devices market are Abbott Laboratories, Biotronik, Bentley InnoMed GmbH, Boston Scientific Corp, Cardiva Medical Inc., Medtronic plc, WL Gore & Associates Inc, Avascular SLU, B. Braun Melsungen AG, Getinge AB, CR Bard Inc (BD), Cook Medical Inc, Terumo Corp, Cardinal Health Inc., Cordis Corp, Endologix Inc and Terumo Medical Corporation.

Recent collaborations and agreements on the market:
In 2020, Medtronic IN. The PACT AV drug-coated balloon (DCB) is approved by the U.S. Food and Drug Administration for the treatment of arteriovenous fistula lesions.
In 2019, the FDA approved Boston Scientific Corporation’s VICI VENOUS STENT system for the treatment of patients with deep venous blockages.

Are you curious about the latest version of the report? Get report details @ https://www.insightaceanalytic.com/report/global-peripheral-vascular-devices-market/1054

Market segments
Global Vascular Peripheral Devices Market by Product Type, 2024-2031 ($Mn Value)
• Aortic stent grafts
• o Arteriotomy closure devices
• o Carotid and renal artery stents
• o Inferior vena cava filters (IVCF)
• o Peripheral anti-embolism devices
• o Peripheral guides, peripheral vascular stents
• o PTA balloon catheters
• o Peripheral drug secretion PTA
• o Balloon catheters (DEB).
• o Renal denervation catheters
• o Terminal locating devices
• o Vascular grafts

Global Vascular Peripheral Devices Market by End User, 2024-2031 (USD Million Value)
• o Hospitals
• o Ambulatory care centers
• o Specialized clinics
• o Others

Global Peripheral Vascular Devices Market by Region, 2024-2031 ($Mn Value)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

North America Peripheral Vascular Devices Market, by Country, 2024-2031 (USD Million Value)
• US
• Canada

European Peripheral Vascular Devices Market by Country, 2024-2031 (USD Million Value)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific Peripheral Vascular Devices Market, by Country, 2024-2031 (USD Million Value)
• India
• China
• Japan
• South Korea
• Australia and New Zealand

Latin America Peripheral Vascular Devices Market, by Country, 2024-2031 (USD Million Value)
• Brazil
• Mexico
• Rest of Latin America

Middle East and Africa Peripheral Vascular Devices Market, by Country, 2024-2031 (USD Million Value)
• GCC countries
• South Africa
• Rest of the Middle East and Africa

Why you should buy this report:
 To obtain a comprehensive analysis of the prospects of the global Peripheral Vascular Devices market
 To get an overview of the industry and future trends in the Peripheral Vascular Devices market
 To analyze the factors influencing the Peripheral Vascular Devices market and challenges
 To get information on Peripheral Vascular Devices Market Value Forecast (USD Million) for 2031
 Significant investments, mergers and acquisitions in the peripheral vascular market industry

For more information @ https://www.insightaceanalytic.com/customisation/1054

[email protected]
InsightAce Analitics Pvt. Sp. z o. o
Visit: www.insightaceanalytic.com
Tel: +1 551 226 6109
Asia: +91 79 72967118
Follow us on LinkedIn @ bit.ly/2tBXsgS
Follow us on Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/InsightaceA

InsightAce Analytic is a market research and consulting company that empowers clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to grow businesses. We help clients gain competitive advantage by identifying untapped markets, discovering new and competitive technologies, segmenting potential markets and repositioning products. Our specialty is delivering syndicated and custom market intelligence reports with in-depth analysis containing key market insights in a timely and cost-effective manner.

This release was published on openPR.